[HTML][HTML] New frontiers in monoclonal antibodies for the targeted therapy of acute myeloid leukemia and myelodysplastic syndromes
M Gallazzi, MAM Ucciero, DG Faraci… - International Journal of …, 2022 - mdpi.com
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) represent an unmet
clinical need whose prognosis is still dismal. Alterations of immune response play a …
clinical need whose prognosis is still dismal. Alterations of immune response play a …
New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes
M Gallazzi, MAM Ucciero, DG Faraci… - INTERNATIONAL …, 2022 - iris.uniupo.it
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) represent an unmet
clinical need whose prognosis is still dismal. Alterations of immune response play a …
clinical need whose prognosis is still dismal. Alterations of immune response play a …
New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes
M Gallazzi, MAM Ucciero, DG Faraci… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) represent an unmet
clinical need whose prognosis is still dismal. Alterations of immune response play a …
clinical need whose prognosis is still dismal. Alterations of immune response play a …
New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
M Gallazzi, MAM Ucciero, DG Faraci… - … Journal of Molecular …, 2022 - europepmc.org
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) represent an unmet
clinical need whose prognosis is still dismal. Alterations of immune response play a …
clinical need whose prognosis is still dismal. Alterations of immune response play a …
New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes
M Gallazzi, MAM Ucciero, DG Faraci… - … Journal of Molecular …, 2022 - research.uniupo.it
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) represent an unmet
clinical need whose prognosis is still dismal. Alterations of immune response play a …
clinical need whose prognosis is still dismal. Alterations of immune response play a …
New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
M Gallazzi, MAM Ucciero, DG Faraci… - International …, 2022 - search.ebscohost.com
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) represent an unmet
clinical need whose prognosis is still dismal. Alterations of immune response play a …
clinical need whose prognosis is still dismal. Alterations of immune response play a …
New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes
M Gallazzi, MAM Ucciero, DG Faraci, AM Mahmoud… - 2022 - agris.fao.org
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) represent an unmet
clinical need whose prognosis is still dismal. Alterations of immune response play a …
clinical need whose prognosis is still dismal. Alterations of immune response play a …
[HTML][HTML] New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes
M Gallazzi, MAM Ucciero, DG Faraci… - … Journal of Molecular …, 2022 - ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) represent an unmet
clinical need whose prognosis is still dismal. Alterations of immune response play a …
clinical need whose prognosis is still dismal. Alterations of immune response play a …
New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes
M Gallazzi, MAM Ucciero, DG Faraci… - … Journal of Molecular …, 2022 - research.uniupo.it
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) represent an unmet
clinical need whose prognosis is still dismal. Alterations of immune response play a …
clinical need whose prognosis is still dismal. Alterations of immune response play a …